The Max Foundation shared on LinkedIn:
“For more than 15 years, Susanna’s treatment kept her chronic myeloid leukemia stable. Then, her test results began to change, and her available options became increasingly limited.
Today, access to another treatment option has brought back something her family feared they were losing: possibility.
Read Susanna’s story from Armenia and learn how our 25-year partnership with Novartis continues to expand access to treatment for patients around the world. The Impact of Partnerships on Patients.”
To which Susan Jerian, President of ONCORD, added:
“Thank you to the Max Foundation, a thousand times over, for making sure cancer patients receive the medicine that they need so matter where they live in the world.
I have witnessed firsthand the high quality and integrity of the Max Foundation.
Looking forward to seeing what the next 5 years have to bring.”
Other articles about Max Foundation on OncoDaily.
